lifestyle.healthsourcemag.com

Author: StarkAge Therapeutics

New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026

April 16, 2026
StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers

January 27, 2026